Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 34962G208 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Tybourne Capital Management (HK) Ltd
13G/A
|
10.0% |
8/4/2025
Event 6/30/2025
|
||
| Tybourne Capital Management (HK) Ltd | 10.0% | |||
| Tybourne Strategic Opportunities GP II Limited | 10.0% | |||
| Tybourne Capital Management Ltd | 10.0% | |||
| Tybourne Kesari Ltd | 10.0% | |||
| Krishnan Viswanathan | 10.0% | |||
| Janus Henderson Group Ltd. 13G/A | 9.3% |
8/13/2026
Event 6/30/2026
|
||
| MPM BioImpact LLC 13G | 7.2% |
5/15/2026
Event 3/31/2026
|
||
|
Orbimed Advisors LLC
13G/A
|
6.2% |
8/14/2026
Event 6/30/2026
|
||
| Orbimed Advisors LLC | 6.2% | |||
| OrbiMed Capital GP IX LLC | 5.1% | |||
| Orbimed Capital LLC | 1.5% | |||
| BlackRock, Inc. 13G | 5.9% |
7/28/2026
Event 6/30/2026
|
||
|
Affinity Asset Advisors, LLC
13G/A
|
5.6% |
8/13/2026
Event 6/30/2026
|
||
| Affinity Asset Advisors, LLC | 5.6% | |||
| Michael Cho | 5.6% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (11) | ||||
|
Ikarian Capital, LLC
13G/A
|
4.99% |
8/14/2025
Event 6/30/2025
|
||
| Ikarian Capital, LLC | 4.99% | |||
| Neil Shahrestani | 4.99% | |||
| Alger Associates, Inc. 13G/A | 4.6% |
8/7/2026
Event 7/31/2026
|
||
|
Adage Capital Management, L.P.
13G/A
|
3.4% |
8/12/2026
Event 6/30/2026
|
||
| Adage Capital Management, L.P. | 3.4% | |||
| Robert Atchinson | 3.4% | |||
| Phillip Gross | 3.4% | |||
|
Millennium Management LLC
13G/A
|
3.2% |
7/16/2026
Event 6/30/2026
|
||
| Millennium Management LLC | 3.2% | |||
| Millennium Group Management LLC | 3.2% | |||
| Israel A. Englander | 3.2% | |||
|
Perceptive Advisors LLC
13G/A
|
2.5% |
2/14/2025
Event 12/31/2024
|
||
| Perceptive Advisors LLC | 2.5% | |||
| Joseph Edelman | 2.5% | |||
| Perceptive Life Sciences Master Fund, Ltd. | 2.5% | |||
|
Oliveira Steven Michael
13G/A
|
2.4% |
1/9/2026
Event 1/8/2026
|
||
| Oliveira Steven Michael | 2.4% | |||
| Nemean Asset Management, LLC | 2.4% | |||
|
Glazer Capital, LLC
13G
|
1.5% |
8/11/2026
Event 8/4/2026
|
||
| Glazer Capital, LLC | 1.5% | |||
| Paul J. Glazer | 1.5% | |||
|
Boothbay Fund Management, LLC
13G/A
|
0.8% |
8/7/2025
Event 6/30/2025
|
||
| Boothbay Fund Management, LLC | 0.8% | |||
| Ari Glass | 0.8% | |||
|
Biotechnology Value Fund L P
13G/A
|
0.5% |
11/14/2025
Event 9/30/2025
|
||
| Biotechnology Value Fund L P | 0.3% | |||
| BVF I GP LLC | 0.3% | |||
| Biotechnology Value Fund II LP | 0.2% | |||
| BVF II GP LLC | 0.2% | |||
| Biotechnology Value Trading Fund OS LP | <0.1% | |||
| BVF Partners OS Ltd. | <0.1% | |||
| BVF GP Holdings LLC | 0.5% | |||
| BVF Partners L P/IL | 0.5% | |||
| BVF Inc/IL | 0.5% | |||
| Lampert Mark N | 0.5% | |||
|
Federated Hermes, Inc.
13G/A
|
0% |
9/8/2026
Event 8/31/2026
|
||
| Federated Hermes, Inc. | 0% | |||
| Voting Shares Irrevocable Trust | 0% | |||
| Thomas R. Donahue | 0% | |||
| Ann C. Donahue | 0% | |||
| J. Christopher Donahue | 0% | |||
|
Point72 Asset Management, L.P.
13G/A
|
0% |
5/15/2026
Event 3/31/2026
|
||
| Point72 Asset Management, L.P. | 0% | |||
| Point72 Capital Advisors, Inc. | 0% | |||
| Steven A. Cohen | 0% | |||